Ifenec (Econazole Nitrate)

Econazole nitrate blocks the fungal enzyme lanosterol 14α‑demethylase, which is essential for synthesising ergosterol, a key component of fungal cell membranes. Inhibiting this pathway disrupts membrane integrity, leading to increased permeability and ultimately death of the Candida cells.

The dose and duration of Ifenec are set by the prescribing clinician based on the severity of the infection, patient age, and any relevant medical history. The product is supplied as a pre‑measured vaginal dosage form, and the healthcare professional will provide specific instructions for each individual.

Safety data for econazole nitrate in pregnancy and lactation are limited. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss potential risks with their healthcare provider before using Ifenec. The prescriber will weigh the benefits against any possible risks to mother and child.

To order Ifenec, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Ifenec (econazole nitrate) belongs to the imidazole class, similar to clotrimazole and miconazole. All act by inhibiting ergosterol synthesis, but econazole may have a slightly broader spectrum against certain Candida strains. Clinical efficacy and safety are comparable; the choice often depends on local guidelines, resistance patterns and patient tolerance.

Ifenec should be stored at room temperature, below 25 °C, in its original packaging to protect it from moisture and light. Keep the product out of reach of children and avoid exposing it to extreme temperatures or humidity, which could affect its stability and effectiveness.

Ifenec is applied intravaginally using the supplied applicator or as directed by a healthcare professional. The patient inserts the dose into the vagina, usually once daily for the prescribed number of days. Proper hygiene, such as washing hands before and after application, helps ensure optimal delivery.

Serious risks, although rare, include severe allergic reactions (e.g., swelling, hives, difficulty breathing) and severe skin reactions such as Stevens‑Johnson syndrome. If any signs of a systemic allergic response or worsening vaginal symptoms occur, the patient should stop use immediately and seek medical attention.

Ifenec should not be used by individuals with a known hypersensitivity to econazole nitrate or any other imidazole antifungal. Patients with severe, uncontrolled diabetes or those with extensive vaginal ulceration should consult a clinician before use, as these conditions may affect treatment outcomes.